Paul Klingenstein, the founder and Managing Partner of Aberdare Ventures. See sector focus and contact routes.
Paul Klingenstein, the founder and Managing Partner of Aberdare Ventures, exclusively invests in transformational healthcare opportunities across sectors including medical devices, pharmaceuticals, health IT, and biotechnology. His firm targets companies from seed to later stages that improve healthcare efficiency and reduce costs, with individual check sizes typically ranging from $500,000 to $15.0 million and a sweet spot around $8.0 million. Notable portfolio companies include Nevro, MC10, Aviir, goBalto (acquired by Oracle), and Ironwood Pharmaceuticals, reflecting a thesis focused on healthcare technology and therapeutic innovations.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in San Francisco.
Investors like Paul Klingenstein · Full investor directory · Investor access · Company funding database